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Bicyclic or tricyclic nitrogen-containing heterocyclic scaffolds were constructed rapidly by intramolecular
nucleophilic aromatic substitution of metallated nitriles tethered by a urea linkage to a series of
electronically unactivated heterocyclic precursors. The substitution reaction constitutes a ring expansion,
enabled by the conformationally constrained tether between the nitrile and the heterocycle. Attack of
the metallated urea leaving group on the nitrile generates a hydantoin that bridges the polycyclic
products. X-ray crystallography reveals ring-dependant strain within the hydantoin.Introduction
Medium (8–12 membered) ring heterocycles are attractive target
structures for medicinal chemistry: their limited conforma-
tional mobility limits unfavourable binding entropy while
allowing three-dimensional organisation of functionality within
the cyclic scaffold.1,2 Medium rings lie at the core of a range of
natural products having biological activities, such as antiviral,
anticancer and anticoagulant agents.1–3 Nonetheless, very few
marketed pharmaceutical agents contain medium rings.4,5 This
can be attributed principally to difficulties associated with their
synthesis, namely the unfavourable transannular interactions
and entropic factors that disfavour the corresponding cyclisa-
tion reactions.6 Simple new synthetic routes to functionally
diverse medium ring heterocycles capable of further function-
alisation are therefore of particular utility.7
Ring expansion is a valuable strategy for the formation of
medium rings, avoiding the difficulties associated with unfav-
ourable cyclisations. Ring-expanding nucleophilic substitutions
have been at the forefront of recent developments in this area.8
We previously reported an operationally simple approach to the
expansion of nitrogen heterocycles (ring size n) into medium
rings (ring size n + 3 or n + 4) by exploiting conformationally
directed intramolecular nucleophilic aromatic substitution
reactions.9–11 Previous work employed powerfully basic urea-
substituted a-aryl organolithium derivatives or allyllithium
derivatives as carbon nucleophiles towards the unreactive,
unactivated aromatic rings.12,13Cantock's Close, Bristol, BS8 1TS, UK.
ESI) available. CCDC 1993726, 1993727,
3732, 1993733, 1993734 and 1993735.
F or other electronic format see DOI:
the Royal Society of ChemistryC–Arylation using N to C migrations of aromatic rings, in the
manner of the Truce–Smiles rearrangement,14,15 is turning out
to be a promising method for the electronically versatile,
transition-metal-free introduction of aromatic substituents,16
also to less basic, more versatile enolate-type nucleophiles: we
recently demonstrated that amino acids may be arylated ster-
eoselectively in this way.17–19 These reactions work because the
conformation of substituted ureas (or amides) bearing an N-aryl
substituent typically favours conformations in which the
carbonyl and aryl group lie trans across the urea (or amide)
linkage.20–24 Given this conformational constraint, nitrile-
stabilised carbanions25 will attack an unactivated C–N bond,
directed by the conformational preference of a urea function
(Scheme 1a), yielding iminohydantoin and hydantoin prod-
ucts.26–28 We now show that the use of such anions in a ring-
expansion reaction of nitrogen heterocycles leads to a two-Scheme 1 Insertion reactions of nitrile-stabilised anions into aromatic
C–N bonds (a) in acyclic systems and (b) leading to the ring-expanding
formation of bridged hydantoins (this work).
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Chemical Science Edge Articlecarbon insertion into an aromatic C–N bond, with tandem
formation of a bridging (imino)hydantoin ring (Scheme 1b).Results and discussion
A general ring-expansion method utilising this type of Truce–
Smiles rearrangement requires an (otherwise unreactive)
precursor heterocycle tethered through a conformationally
preorganised urea to a nucleophile. We therefore chose to start
with the a-cyanourea, 1a, synthesised in three steps from
commercially available starting materials. Treatment with base,
optimally 2 equiv. KHMDS in THF at 0 C, initiated a deproto-
nation–rearrangement-cyclisation cascade that led directly to
the tricyclic iminohydantoin 2a in 73% yield (Scheme 2), the
structure of which was conrmed by X-ray crystallography.
Similar ring-expanding rearrangements to remarkable tricyclic
products 4 and 6 occurred in even higher yield, starting from
the 7- and 8-membered heterocycles 3 and 5.
Deprotonation by KHMDS must generate from each of these
starting materials, at least to some extent, the anion 7, which
attacks the adjacent electron-rich aromatic ring in a conforma-
tionally enforced intramolecular SNAr reaction (Scheme 2). The
lack of electron-withdrawing substituent on the arene does notScheme 2 Ring-expansion of metallated nitriles. Conditions: a (1)
KHMDS (2 equiv.), THF, 0 C, 0.5–1.5 h; (2) MeOH. CCDC deposition
numbers for X-day data: 2a 1993726; 4 1993727.†
2092 | Chem. Sci., 2021, 12, 2091–2096stop this reaction taking place, and we propose that this
proceeds by the partially concerted addition–elimination
mechanism that is typical for SNAr reactions of less activated
arenes.17,29–31 The product urea anion 8 cyclises onto the cyano
group25 to generate an iminohydantoin anion 9, which is
protonated to yield the product.
The time course of the reaction of 3 with KHMDS was fol-
lowed by in situ infra-red spectroscopy (ReactIR) at 5 C (Fig. 1
and ESI†). The carbonyl absorption of 3 at 1654 cm1 (A) shied
transiently to 1663 cm1 (B) on addition of KHMDS (t¼ 18 min)
and then immediately (within 15 s) back to 1660 cm1 (C) for
the remainder of the reaction period. The shi was accompa-
nied by the appearance of an absorption at 1737 cm1 (B, C).
The nal quench (t ¼ 108 min) forms the product 4 with
absorptions at 1662, 1736 and 1743 cm1 (D). The absorptions
of C were assigned to anion 9 by comparison of C with the IR
spectrum produced on treatment of 4 with KHMDS and are
analogous to those seen in related unbridged hydantoins, but at
frequencies about 15 cm1 higher. The deprotonation to give 7
and rearrangement to 8 and cyclisation to 9 appear to be
instantaneous under these conditions, as no absorptions typical
of urea anions (7 and 8) were detected. The product resulting
from direct protonation of 8 was not observed.
The versatility of the ring-expansion method was explored by
varying the starting tetrahydroquinoline scaffold 1. Related
structures 2b–2d (Scheme 3) were formed in moderate yield
from starting materials carrying either electron-donating or
electron-withdrawing substituents on the migrating aromatic
ring, consistent with the tolerance of related rearrangements of
ureas to both electron-rich and electron-decient rings.
Substituted rings in which one of the atoms of the tether was
replaced with a heteroatom also migrated, to give the bridged
thiazocane and oxazocane, 2e and 2f, although competing
elimination reactions reduced the yield of these reactions.32
Substitution on the aliphatic ring of the starting material was
tolerated, with 2-methylquinoline derivative 1g giving the ring-
expanded product 2g as a mixture of diastereoisomers, the
major one being identied by X-ray crystallography. For
medium ring products 2a, 2e and 2f cleavage of the urea alsoFig. 1 Time-course of the reaction of 3with KHMDS followed at5 C
in THF by in situ infra-red spectroscopy. A: 3 in THF at5 C; B: (t¼ 18
min) KHMDS (2 equiv.) added; C: reaction mixture at 5 C. D: (t¼ 108
min): reaction quenched by addition of MeOH.
© 2021 The Author(s). Published by the Royal Society of Chemistry
Scheme 3 Ring-expansion of substituted tetrahydroquinolines.
Conditions: a (1) KHMDS (2 equiv.), THF, 0 C, 1–2 h; (2) MeOH.a 2g0 is
the diastereoisomer of 2g shown. CCDC deposition numbers for X-
day data: 2f 1993728; 2g 1993729.†
Scheme 4 Ring expansion to polycyclic scaffolds. Conditions: a (1)
KHMDS (2 equiv.), THF, 0 C, 1–1.5 h; (2) MeOH. aAccompanied by
products of urea cleavage. bA lactam resulting from oxidation of 10
was isolated in 26% yield. CCDC deposition numbers for X-day data:
11a 1993730; 11f 1993731; 11g 1993732.†
Edge Article Chemical Scienceoccurred and the starting tetrahydroquinoline was isolated in
low yield.
Cyclic aminonitriles are readily available commercially, or by
reductive cyanation. Molecular scaffolds with further
complexity were formed by employing these cyclic aminonitriles
as starting materials. Thus 2-cyanopyrrolidine and piperidine
carbamoyl chloride derivatives were coupled with benzo-fused
nitrogen heterocycles to provide ureas 10a–g. Treatment with
base generated anions that rearranged to the polycyclic struc-
tures 11a–g (Scheme 4). Yields were ring-size dependent, with
the general trend, parallel to that seen in Schemes 1 and 2, that
larger rings formed in greater yield than the smaller. Formation
of 11d was accompanied by products of urea cleavage. With 11e,
no elimination products were noted but a by-product resulting
from oxidation of 10 a to the cyano group and elimination of
cyanide was isolated in 26% yield (see ESI†).
More elaborate ring systems were made by incorporating
additional nucleophilic sites into the starting structures
(Scheme 5). For example, 12, which is the keto-derivative of 3a,
underwent a tandem migration-cyclisation to give 13, in which
the ketone's enolate has attacked the iminohydantoin,
presumably to relieve transannular strain across the interme-
diate 10-membered ring. A similar transannular interaction was
enabled by ring expansion of the benzopiperazine derivative 14.
The initial stable Boc-protected product 15 was formed in good© 2021 The Author(s). Published by the Royal Society of Chemistryyield, but deprotection of the Boc group and concomitant
hydrolysis of the imine led directly to the polycycle 16.
An alternative benzopiperazine-derived staring material, 17,
incorporates a second cyanoalkyl group that is capable of
deprotonation. And indeed, treatment of 17 with four equiva-
lents of KHMDS induced two successive ring expansions,
enlarging the six-membered ring of the starting material twice,
to form 18 with a peripheral 12-membered ring bridged by two
iminohydantoins. Two diastereoisomers were formed in
a 74 : 26 ratio, the minor (18b) being the C2 symmetric diaste-
reoisomer (racemic by HPLC on chiral stationary phase, see
ESI†) and the major (18a) being the meso compound (identied
by X-ray crystallography).
Both iminohydantoins and hydantoins33,34 (including
bridged structures32) exhibit various biological activities.
Representative iminohydantoins 2a, 2g and 2g0 were trans-
formed into their hydantoin congeners by hydrolysis with acid.Chem. Sci., 2021, 12, 2091–2096 | 2093
Scheme 5 Ring-expansion of substituted tetrahydroquinolines.
Conditions: a (1) KHMDS (2 equiv.), THF, 0 C, 1–1.5 h; (2). MeOH; b 2 M
HCl : MeOH (1 : 1), reflux, 44 h. c (1) KHMDS (4 equiv.), THF, 0 C, 5 h.
(2) MeOH. CCDC deposition numbers for X-day data: 16 1993733; 18a
1993734.†
Scheme 6 Hydrolysis of fused iminohydantoins to yield hydantoins.
Conditions: a 2 M HCl : TFA (1 : 9), mW, 120 C, 2 h; b 2 M HCl : MeOH
(1 : 1), 70 C, 44 h. CCDC deposition number for X-day data: 2g–h
1993735.†
Table 1 Structural parameters
Ring size
n N1 DSqa C2 DSqa C2 Ddb N3 DSqa C4 DSqa C4 Ddb
—c 1.2 0.0 0.0d 0.1 0.0 0e
10f 2.9g 0.0 0.9 2.4 0.2 4.6
9h 2.1g 0.0 3.9 4.6 0.1 1.3
8i 2.1 0.0 5.9 13.4 0.0 0.6
a DSq ¼ deviation from planarity ¼ 360 – sum of bond angles. b Dd ¼
Change in chemical shi from the average value of 2 representative
hydantoins. c Values for representative monocyclic hydantoins
(structures given in ESI) taken from ref. 37–40. d d ¼ 155.3 ppm (average
of 2 values37). e d ¼ 173.7 ppm for iminohydantoins only (average of 2
values37). f Data taken from X-ray crystal structures of 11g and 18a.
g Excluding structures where this atom lies at a ring junction. h Data
taken from X-ray crystal structures of 4, 11a, 11f. i Data taken from X-
ray crystal structures of 2a, 2f, 2g.
Chemical Science Edge ArticleThe iminohydantoins were either reuxed in 1 : 1 mixture of
methanol and hydrochloric acid or irradiated in a microwave in
a mixture of hydrochloric acid with triuoroacetic acid, yielding
hydantoins in moderate to good yield (Scheme 6).
Typical hydantoins are stable, more or less planar rings.
Those formed by this insertion reaction contain a bridgehead
nitrogen that is formally sp2-hybridised, but for which full
planarity would contravene Bredt's rule.35,36 To explore the effect
of imposing the constraint of a medium ring on the geometry of
the hydantoin, bond angles in the X-ray crystal structures of the
iminohydantoin and hydantoin products were compared with
those from X-ray crystal structures of a sample of 5 simple,
monocyclic hydantoins.37–40 Table 1 tabulates some of these
data according to ring size. The most notable structural change
occurred at N3. In the monocyclic hydantoins, this atom is
planar, but decreasing the ring size of the tether (which links
through this atom) led to greater pyramidalization of this N
atom. The size of the medium ring linkage had little effect on
N1. Both C2 and C4 remained essentially planar even in the
smaller, more strained rings. However, increased ring strain2094 | Chem. Sci., 2021, 12, 2091–2096had a signicant effect on the 13C NMR shi of C2, which
moved upeld with increasing strain.
Conclusions
In summary, a urea linkage between an aminonitrile and
a benzo-fused nitrogen heterocycle enables the anion of the© 2021 The Author(s). Published by the Royal Society of Chemistry
Edge Article Chemical Scienceaminonitrile to act as a nucleophile in an SNAr substitution on
the unactivated arene of the heterocycle. A ring expansion by
two atoms results, giving an iminohyantoin-bridged medium
ring in which the nitrile anion has formally inserted into the
ArC–N bond of the heterocycle. The product iminohydantoin
ring of the polycycle product may be hydrolysed to a hydantoin,
giving functionalised bridged and caged structures of potential
utility in medicinal chemistry lead generation.
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